drugset / Trial / NCT04146116

Nasal Decolonization for Orthopedic Trauma Patients

NCT04146116

NaSingle-groupOpen-labelPrevention

Summary

Many surgical site infections are caused by bacteria that is transferred from a patient's nose to their open surgical wound. Some small studies have shown that putting povidone-iodine in a patient's nose reduces this risk. This study aims to evaluate the real-world effectiveness of nasal povidone-iodine (PROFEND®) in a group of 50 patients at the University of Iowa.

Timeline

Start
2020-02-19
Primary completion
2021-06-08
Completion
2021-06-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Povidone-Iodine Other / unclassified 10 % Intranasal

Indications

No indication recorded.